Corindus

Corindus is a company specializing in the development, production, and marketing of remote robotic systems for interventional procedures. Since its founding in 2002, the company has been committed to designing and manufacturing advanced robotic systems, including the innovative CorPath system. This system enables physicians to conduct catheterization procedures remotely, reducing their exposure to radiation. Based in Waltham, Massachusetts, the company operates within the manufacturing, medical devices, and robotics industries. In February 2019, Corindus secured a noteworthy $19.50 million in post-IPO equity investment. This financial backing was provided by BioStar Capital and Hudson Executive Capital, both prominent investors in the healthcare and technology sectors. This funding is indicative of the confidence investors have in Corindus' robotic systems and their potential impact on the interventional medicine market.